Follow
Bernard Hirschel
Bernard Hirschel
Unknown affiliation
Verified email at hirschel.ch
Title
Cited by
Cited by
Year
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
21012003
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
Data Collection on Adverse Events of Anti-HIV Drugs Study Group
Archives of internal medicine 166 (15), 1632-1641, 2006
14862006
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
A Rauch, Z Kutalik, P Descombes, T Cai, J Di Iulio, T Mueller, M Bochud, ...
Gastroenterology 138 (4), 1338-1345. e7, 2010
14542010
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
G Greub, B Ledergerber, M Battegay, P Grob, L Perrin, H Furrer, ...
The Lancet 356 (9244), 1800-1805, 2000
12402000
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
11552008
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
B Ledergerber, M Egger, M Opravil, A Telenti, B Hirschel, M Battegay, ...
The Lancet 353 (9156), 863-868, 1999
11121999
Maraviroc for previously treated patients with R5 HIV-1 infection
RM Gulick, J Lalezari, J Goodrich, N Clumeck, E DeJesus, A Horban, ...
New England Journal of Medicine 359 (14), 1429-1441, 2008
9062008
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
S Simioni, M Cavassini, JM Annoni, AR Abraham, I Bourquin, V Schiffer, ...
Aids 24 (9), 1243-1250, 2010
8892010
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
M Egger, B Hirschel, P Francioli, P Sudre, M Wirz, M Flepp, M Rickenbach, ...
Bmj 315 (7117), 1194-1199, 1997
7671997
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study
B Ledergerber, M Egger, V Erard, R Weber, B Hirschel, H Furrer, ...
Jama 282 (23), 2220-2226, 1999
6241999
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study
GR Kaufmann, L Perrin, G Pantaleo, M Opravil, H Furrer, A Telenti, ...
Archives of internal medicine 163 (18), 2187-2195, 2003
5552003
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
J Fellay, B Ledergerber, E Bernasconi, H Furrer, M Battegay, B Hirschel, ...
The Lancet 358 (9290), 1322-1327, 2001
4832001
Les personnes séropositives ne souffrant d’aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle
P Vernazza, B Hirschel, E Bernasconi, M Flepp
Bulletin des médecins suisses| Schweizerische Ärztezeitung| Bollettino dei …, 2008
4772008
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study
N Friis-Mřller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ...
European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010
4352010
Characteristics, Determinants, and clinical relevance of CD4 T cell recovery to< 500 cells/µL in HIV type 1—infected individuals receiving potent antiretroviral therapy
GR Kaufmann, H Furrer, B Ledergerber, L Perrin, M Opravil, P Vernazza, ...
Clinical infectious diseases 41 (3), 361-372, 2005
4332005
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection
G Fätkenheuer, M Nelson, A Lazzarin, I Konourina, AIM Hoepelman, ...
New England Journal of Medicine 359 (14), 1442-1455, 2008
4252008
Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen
N Sachsenberg, AS Perelson, S Yerly, GA Schockmel, D Leduc, ...
The Journal of experimental medicine 187 (8), 1295-1303, 1998
4041998
HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study.
M Opravil, M Pechčre, R Speich, HI Joller-Jemelka, R Jenni, EW Russi, ...
American journal of respiratory and critical care medicine 155 (3), 990-995, 1997
3801997
A controlled trial of zidovudine in primary human immunodeficiency virus infection
S Kinloch-de Loës, BJ Hirschel, B Hoen, DA Cooper, B Tindall, A Carr, ...
New England Journal of Medicine 333 (7), 408-413, 1995
3561995
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1–infected adults treated with combination antiretroviral therapy
H Furrer, M Egger, M Opravil, E Bernasconi, B Hirschel, M Battegay, ...
New England Journal of Medicine 340 (17), 1301-1306, 1999
3541999
The system can't perform the operation now. Try again later.
Articles 1–20